Matthew Marsh
Analyst · Simon Thackray from Citigroup
Thanks, Louis. On Slide 19, it's probably apparent from our release and Louis' comments, we've had an increase in volume and revenue in the quarter in most of our major business units. We had a favorable asbestos adjustment in the quarter as well related to the depreciation of the Aussie dollar versus the U.S. dollar. If we go to Slide 20, you can see the reported profit of $92.2 million with sales up 10% for the quarter. Gross profits were $121.5 million for the quarter, up 26%. So seeing the impact of price and the volume efficiencies come through with good leverage. You see SG&A expenses decreased primarily due to a decrease in the legacy New Zealand product liability settlements. And then they're partially offset by some higher corporate costs. And then finally, there was a noncash asbestos adjustment that you'll see noted there. And that was really an impact as a result of the depreciation in the Australian dollar exchange rate against the U.S. dollar compared to the prior corresponding period. If we go to Slide 21, the normalized earnings that we look at are on this page, where we have net operating profit excluding the various items of $43.7 million in comparison to $26.7 million from Q3 of 2013, representing a 64% increase. The legacy, as I mentioned, on the prior page, the legacy New Zealand product liability moved from a $7.5 million expense in the prior corresponding quarter to a $4 million -- $4.2 million benefit in the current quarter. Again, you'll note the asbestos adjustment's driven by the effect of foreign exchange and total net operating profit for the period of 64%. On Slide 22, for the 9 months, we reported operating profits of $286.3 million versus the 9-month period ending in 2013 of $115 million. Again, net sales and gross profits were both favorably impacted, as we've discussed, by volume and average selling price. R&D expenses decreased, you'll note, slightly -- largely just the result of the completion of certain core projects. And then again, the noncash asbestos adjustment at the end of December period impacted by foreign exchange rate movements. On Slide 23, for the 9 months, you see our improved headline net operating profit number, again, driven by sales and our gross profit. You'll see a net operating profit excluding the various items of $152 million, up 39% from the 9 months ending 2013, where we reported $109.4 million. And then similarly, asbestos adjustments driven by the effect of FX and excluding asbestos, asset impairment, ASIC expenses in New Zealand, product liability, NOPAT for the 9 months, up 39%. On Slide 24, the segment EBIT. So the U.S.A. and Europe Fibre Cement segment, up -- EBIT up 75%, as well as the Asia Pacific Fibre Cement segment, up 11%. The adjusted U.S. and Europe segment had EBIT margins of 20.2% for the period, up 6.7 percentage points from the prior corresponding period. And similarly with Asia Pacific, reported EBIT margins increased 3.5 percentage points, up to 23.5%. So both major operating divisions have EBIT margins in the ranges that we've expected. If we go to Slide 25, segment EBIT for the 9 months, similar dynamics to the 3 months. So the U.S. and Europe segment reported $179.8 million for the 9 months ending FY '14, up 44% from the 9 months ending 2013. And Asia Pacific, up 11%. Again, their EBIT margins for U.S. and Europe, up 390 basis points to 21.4%. And Asia Pacific EBIT margin's up 240 basis points to 23.2%. You'll note here, general corporate costs were higher compared to the prior corresponding period, primarily due to some salary and compensation increases. But additionally, the prior period had some favorable items that were nonrecurring for the current period. On Slide 26, a familiar picture that we find useful to see what's going on with the major currency. There's been a 12% depreciation of the Aussie dollar versus the prior corresponding period and an 8% depreciation in our financials on a 9-month basis year-to-date. And at the bottom of the page, you'll see that, that translates through to our financial statements in a similar format for what we've showed you in the past. On Slide 27, income tax expense for the quarter of $11.7 million was up $4.5 million versus Q3 2013. Our effective tax rate in the third quarter of 2014 was 21.1%, largely in line with where it was a year ago. Page 28, income tax for the 9 months was an expense of $41.7 million for the 9 months 2014, up $9.2 million for the 9-month period of 2013, where we paid $32.5 million -- or sorry, we had an expense of $32.5 million. You'll see the movement on the effective tax rate in the 9 months of '14 of 21.5%, down from 23%. You may note that we had missed our forecast in the 9-month projection of 2013. And at year-end, our actual effective tax rate for 2013 was 21.3%. So on that basis, a very comparable business tax rate. On Slide 29, cash flows. So net operating cash flows increased for the 9 months from $83.3 million to $254.7 million, really driven by a few factors. Number one, the prior year had a nonrecurring tax payment of $81.3 million related to the favorable conclusion of the RCI-disputed disclosure 1999 tax assessment; Number two, a decrease in the company's contribution to AICF as we didn't make a payment through the first 9 months of this year; and higher earnings as a result on -- higher earnings net of asbestos adjustments as a result of the operating performance that we've talked about in this release. An increase in net capital expenditures, primarily the result of a combination of previously purchased leased land and buildings at Carole Park, as well as the Fontana refurbishment. You'll see dividends have been paid through the first 9 months of $163.6 million with an ending net cash of $185.2 million through the first 9 months, which is a good result in light of the level of dividends that we've paid through the year. And it just reinforces the operating division's strength through the first 9 months. On Slide 30, capital expenditures of $73.3 million for the 9 months, up 75% from the 9 months of the prior corresponding period, largely driven by, as I mentioned, the Carole Park, Brisbane plant and building, Fontana, which Lou's already talked about. And capital expenditures do include capital assets of $4.8 million related to a fiberglass windows business acquisition that we closed in December of 2013. On Slide 31, capital management has become more of a focus, and it will be more of a focus now and into the future. And following a review of our capital management strategy, we've outlined the objectives and framework that you see on this page. Our objective of capital management is to optimize our capital structure with a view towards the target net debt position in the range of 1 to 2x of adjusted EBITDA. And while dependent on the below factors I'll discuss in a second, we're targeting a net debt north of $500 million. The absolute level of debt will really depend on a number of factors, including but not limited to, the internal needs to finance growth via capital expenditures and investing appropriately in research and development, where we believe we are in an operating economic cycle; the objective of providing a consistent and ordinary dividend; ensuring sufficient liquidity buffers for unexpected challenges, and giving us a buffer for strategic opportunity as well; and then an overarching objective to minimize our cost of capital. So our objective is to move swiftly in this direction through the full extent of this approach. But it may take some time for this to fully play out. On Slide 32, some additional items on capital management. So today, we announced 125-year anniversary special dividend of $0.28 per security in recognition of our celebration last year of our 125th-year company anniversary. That dividend is declared in the U.S. currency. It'll be paid on the 30th of May 2014 with a record date of 21 March 2014. In November, we announced an increase of our dividend payout ratio to 50% and 70%. We continue to operate under that. And then in November, you'll also note that we announced an ordinary first-half dividend of $0.08 per security, up from $0.05 in the prior corresponding fiscal year. And that was declared also in U.S. currency and will be paid on the 28th of March 2014. On share buybacks, in May of 2013, we announced the share buyback program to acquire up to 5% of our issued capital. As of today, we repurchased just over 1 million shares of our common stock with an aggregate U.S. value of about $12.2 million and an average market price of AUD 11.94. On Slide 33, debt. We have total facilities of $405 million at the end of the period, 31 December, which are adequate. We have a ending net cash balance of $185.2 million and giving us total liquidity at the end of the third quarter of $590.2 million On Slide 34, an update on New Zealand product liability and Ministry of Education. On New Zealand product liability, an item familiar to you from a prior-quarter releases that we've had. In the third quarter, we did recognize a benefit of $4.2 million due to favorable settlement activity in the 3 months ending 31 December. For the 9 months, we did recognize an expense of $700,000 to reflect the movements and the provisions for new and existing claims during the current fiscal year. Regarding New Zealand, the New Zealand Ministry of Education representative action. In April of last year, the Ministry of Education filed a representative action against 2 of our subsidiaries in New Zealand. In December, we finalized the commercial settlement with the Ministry of Education. And while the terms of that settlement are confidential and the settlement did not have a material adverse effect on our financial position or on the result of our operations or cash flow. So if we go to Slide 35, the asbestos fund. So as of 31 December, AICF had paid claims of $104.6 million and ended 31 December with cash and investments of $69.4 million. There -- I will note, there was an increase in asbestos claims during the 9 months. We are monitoring the claims activity closely. But as we said in the November result, at this stage, the increase isn't clear if it's a change in the trend or a random variation. Previously, we've seen upticks in one period and only for the claims to settle at a lower level in the next periods. As I think many of you know, KPMG and AICF will issue the annual actuarial study in a few months. And that will be our next best indication of how the activity through the 9 months is playing out. On Slide 36, we do expect full year earnings, excluding asbestos asset impairment, ASIC expenses, New Zealand product liability and tax adjustments to be $190 million to $ 200 million. Obviously, that's dependent on, among other things, the housing industry in the U.S. and Australia. Average exchange rates, we've assumed an average exchange rate of U.S. 89 to Aussie. And although U.S. housing activities have been improving sometime -- for some time, the market conditions do remain somewhat uncertain with some of the recent weather activity, especially. If we go to Slide 37, in summary, net operating profit, excluding asbestos asset impairment and the other items are $43.7 million for the quarter and $152 million for the 9 months, largely driven by higher volume in the U.S. and Europe segment, as well as Asia Pacific on price. Higher EBIT margins in both major operating divisions. We're continuing to invest in production capacity expansion, as Louis noted, in Fontana, Cleburne and Plant City. The special dividend of $0.28 per security in recognition of our 125th-year anniversary. And through the first 9 months, we paid a total of $163.6 million of dividends and for fiscal year 2014, the first half dividend of $35.5 million to be paid in March of this year.